Page 5,786«..1020..5,7855,7865,7875,788..5,8005,810..»

Extended Benefits Needed for Veterans Who Suffer with Traumatic Brain Injury

Posted: Published on January 30th, 2013

COMMENTARY | Simply put, "war is hell," and this may one of the most important factors on determining why unmitigated benefits for veterans that suffer with service-connected traumatic brain injury receive optimum health care related to this distressing crisis. My heart goes out to all of the men and women who served in the armed forces, especially scores of those who are suffering from a variety of depression and anxiety related to traumatic brain injury. My veteran status does allow me to receive treatment for anxiety and depression, a benefit that I do not take for granted. At some point in my four-year tenure as a Coast Guard Seaman, there was one incident where I had to receive an MRI due to a freak accident. If I were not a full-time Coast Guardsmen during the 1980s, my hospital price tag would have cost me thousands of dollars. Today's post-war veterans deserve the best treatment related to traumatic brain injury. President Obama's nominee for Department of Defense, Chuck Hagel, can play a pivotal role at how much care these post-war veterans will be able to receive. It has become abundantly clear that the war in the Middle East is a sobering … Continue reading →

Posted in Brain Injury Treatment | Comments Off on Extended Benefits Needed for Veterans Who Suffer with Traumatic Brain Injury

Feature: MS MR unmasked: “We never intended to be this mysterious band”

Posted: Published on January 30th, 2013

Ahead of their appearance at Laneway Festival, DARREN LEVIN unmasks the duo behind New Yorks Tumblr-glitch-pop duo MS MR. In an age of full disclosure and rampant TMI, New Yorks MS MR did a very unusual thing indeed. They kept their identities under wrap long enough to release a debut EP, Candy Bar Creep Show, last year through Tumblr of all places, only revealing their true selves when their music had properly hit critical mass. Now, the cats out of the bag: The band is helmed by Neon Gold Records founder Lizzy Plapinger and Idaho-born producer Max Hershenow, who have turned their dark and mysterious bedroom project into a fully-fledged Tumblr-glitch-pop band (their words). Ahead of their debut Australian tour for [aa,artist:Laneway Festival], the pair spoke rather excitedly to FL about their developing live show, a forthcoming full-length album and the importance of anonymity. I bet you didnt think youd be talking to a journalist in Australia a year ago. Lizzy: [Laughs] No, we definitely didnt. Max: Weve been blown away by the experience so far. Lizzy: But now its really lovely. We have an Australian connection. Do you know much about Laneway? Lizzy: Weve been fans of the festival … Continue reading →

Posted in MS Treatment | Comments Off on Feature: MS MR unmasked: “We never intended to be this mysterious band”

Rogue Immune Cells Tied to MS Point to New Drug Target

Posted: Published on January 30th, 2013

Researchers identified a possible culprit for immune cells resistance to regulation in a small study of multiple sclerosis patients, suggesting a potential new target for treatment. T-cells, when working properly, are an important part of the immune systems arsenal for fighting off invaders. In MS patients, however, they can ignore the controlling orders from regulatory cells and attack the central nervous system, researchers found in a study published today in the journal Science Translational Medicine. Scientists at Virginia Mason Medical Center in Seattle identified a protein called interleukin-6, or IL-6, as a reason for those cells going rogue in patients with relapsing-remitting MS, the most common form of the disease. We identified a new problem in multiple sclerosis that hadnt been identified before, Jane Hoyt Buckner, an author of the paper and associate director of Virginia Masons Benaroya Research Institute, said today in a telephone interview. Then we were able to show why that happens in MS patients, which is this enhanced responsiveness to the cytokine IL-6. People with relapsing-remitting MS have more receptors for IL-6 on the surface of their T-cells, suggesting IL-6 may be a good target for therapy, Buckner said. More than 2.1 million people worldwide have … Continue reading →

Posted in MS Treatment | Comments Off on Rogue Immune Cells Tied to MS Point to New Drug Target

AFD TV Health and Wellness videos – Video

Posted: Published on January 30th, 2013

AFD TV Health and Wellness videos By America's Family Doctors AFDclinics.com wellness bioidentical Hormone Replacement Team By: afdclinics … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on AFD TV Health and Wellness videos – Video

Once-monthly HGH replacement therapy gets $25 million VC boost for pediatric trial

Posted: Published on January 30th, 2013

For the thousands of adults and children with growth hormone deficiencies, daily injections of replacement hormones are their best bet for preventing the cardiovascular, muscular and metabolic abnormalities associated with the condition. But a few companies are on the hunt for ways to make those injections last longer so that they would require less frequent administration and result in fewer side effects. One of those companies is biotechnology firm Versartis Inc., which has just closed a $25 million series C, according to U.S. Securities and Exchange Commission filings and a company announcement. Aisling Capital led the financing round, which also saw participation from existing investors Index Ventures, New Leaf Venture Partners and Advent Venture Partners Advent Life Sciences fund. Versartis uses technology called XTEN to extend the half-life of proteins. It thinks compounds it develops using XTEN technology could provide more stable and convenient therapies with enhanced efficacy and fewer side effects. Its lead product, VRS-317, applies XTEN to recombinant human growth hormone and is being developed to address growth hormone deficiencies in children and adults. The financing will fund Versartis phase 1/2 study of VRS-317 in pediatric patients thats being conducted at 30 sites across the U.S. A phase … Continue reading →

Posted in Hormone Replacement Therapy | Comments Off on Once-monthly HGH replacement therapy gets $25 million VC boost for pediatric trial

Stem Cell Transplantation for Spinal Cord Injury – Video

Posted: Published on January 30th, 2013

Stem Cell Transplantation for Spinal Cord Injury Presented by Dr. Charles Tator Professor of Neurosurgery, University of Toronto Division of Neurosurgery, Toronto Western Hospital Topics: - Why it has been extremely difficult to develop effective strategies to improve recovery after sci - Neural or Non-Neural Cells which are better for transplantation? - Endogenous vs. Exogenous (transplanted) Neural Stem Cells? -- which source is better? - Developmental Age of the Transplanted Cells - Embryonic, Fetal, Neonatal, or Adult?-which is better? - If adult cells, what is best source of cells? Spinal Cord or Brain? For a PDF version of Dr. Charles Tator's presentation please go to: http://www.thomsonrogers.com/past-conference-2012#tator By: Thomson Rogers … Continue reading →

Posted in Stem Cell Research | Comments Off on Stem Cell Transplantation for Spinal Cord Injury – Video

Stem Cell Reprogramming Video – Video

Posted: Published on January 30th, 2013

Stem Cell Reprogramming Video stem-cell-reprogramming-juan-carlos-belmonte-phd By: AHJDietNWeightLoss … Continue reading →

Posted in Stem Cell Research | Comments Off on Stem Cell Reprogramming Video – Video

Dear Religeon (an open letter) or Why Adam and Eve it? – Video

Posted: Published on January 30th, 2013

Dear Religeon (an open letter) or Why Adam and Eve it? Dear religion, Kindly stop deceiving yourself and others, grow up and take responsibility for your actions, and the actions of what others do in your name. If you want to be taken seriously you would not contradict yourself, and If you want to be believed, you would and should be able to back up your claims with reliable and certifiable evidence. If you want to be thought off as benevolent, why hinder the advancement of treatments that work to cure people? (Like stem cell research). If you want us to be good to everyone why do you have such hate and intolerance to others in your writings. All of you can't all be right as you all claim to be, that leads me to the conclusion that none of you are right. As you built and expanded on from each other's ideas. (If even one thing is in error then your whole premise fails) and I'm looking at you Adam Eve. If you can prove that none of your authors were delusional, and that anything you say can't be explained away within the historical political … Continue reading →

Posted in Stem Cell Research | Comments Off on Dear Religeon (an open letter) or Why Adam and Eve it? – Video

Stem cell agency not doing enough to avoid conflict of interest

Posted: Published on January 30th, 2013

Compromise, defined as the art of getting part of a loaf when the whole loaf is out of reach, comes in many forms. But surely the strangest of all is what comes of trying to compromise with yourself. That's what California's stem cell agency is attempting to do. And judging from its record of pioneering new ways of funding and managing scientific research, you can rest assured that the results will be fraught with interest. What's at issue is how the agency's board wrestles with recommendations for changes in its membership and its authority over the spending of its $3-billion endowment in state bond funds (that's $6 billion, including interest). The recommendations came last month from a panel of the Institute of Medicine, an arm of the National Academy of Sciences. The stem cell agency, which is formally known as the California Institute for Regenerative Medicine, or CIRM, paid the academy $700,000 for this exercise in high-level scrutiny. After 17 months of deliberation, the panel, which was chaired by Harold Shapiro, a former president of Princeton University, concluded that the CIRM board members were saddled with "almost unavoidable conflicts of interest, whether actual or perceived." That's because by law, 23 … Continue reading →

Posted in Stem Cell Research | Comments Off on Stem cell agency not doing enough to avoid conflict of interest

In a Canadian first, family practice offers genetic testing with CAMH to predict which psychiatric meds work best

Posted: Published on January 30th, 2013

TORONTO, Jan. 30, 2013 /CNW/ - For the first time in Canada, patients attending a family practice clinic will be offered genetic testing to see whether or how they will respond to psychiatric medication treatment, in partnership with the Centre for Addiction and Mental Health (CAMH). Thornhill Medical Centre, a clinic of family physicians, is making the promise of personalized medicine a reality. "These pharmacogenetic tests will enable physicians to use a patient's genetic makeup to help predict which medications are safe to prescribe, and which ones may be ineffective or cause side effects," said Dr. James Kennedy, head of CAMH's Neuroscience Research Department. The tests, which will prevent trial-and-error prescribing and reduce associated health-care costs, will be analyzed in the Tanenbaum Centre for Pharmacogenetics at CAMH's Campbell Family Mental Health Research Institute. "My patients were ready for these tests yesterday - they may have tried three or four different antidepressants that didn't work or had side effects, before finding something that helped them," Dr. Nick Voudouris, a family physician with the Thornhill Medical Centre. "The ability to be able to know which medications patients will respond to, based on their genetic predisposition, is invaluable." Using a saliva sample, variations … Continue reading →

Comments Off on In a Canadian first, family practice offers genetic testing with CAMH to predict which psychiatric meds work best

Page 5,786«..1020..5,7855,7865,7875,788..5,8005,810..»